RTA1 Stock Overview
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
+ 1 more risk
Rite Aid Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.20 |
| 52 Week High | US$2.80 |
| 52 Week Low | US$0.13 |
| Beta | 1.32 |
| 1 Month Change | 0% |
| 3 Month Change | -51.22% |
| 1 Year Change | -90.20% |
| 3 Year Change | -98.65% |
| 5 Year Change | -97.54% |
| Change since IPO | -99.96% |
Recent News & Updates
Recent updates
Shareholder Returns
| RTA1 | DE Consumer Retailing | DE Market | |
|---|---|---|---|
| 7D | 0% | -1.8% | -2.0% |
| 1Y | -90.2% | -35.5% | -0.3% |
Return vs Industry: RTA1 underperformed the German Consumer Retailing industry which returned -35.5% over the past year.
Return vs Market: RTA1 underperformed the German Market which returned -0.3% over the past year.
Price Volatility
| RTA1 volatility | |
|---|---|
| RTA1 Average Weekly Movement | n/a |
| Consumer Retailing Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: RTA1's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine RTA1's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1962 | 47,000 | Jeffrey Stein | www.riteaid.com |
Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and provides various other pharmacy services and an assortment of products comprising over-the-counter medications, health and beauty aids, personal care products, seasonal merchandise, cosmetics, household items, food and beverages, greeting cards, seasonal and seasonal merchandise, pet care, and a variety of other everyday and convenience products, as well as brand and generic prescription drugs; and a private brand product line.
Rite Aid Corporation Fundamentals Summary
| RTA1 fundamental statistics | |
|---|---|
| Market cap | €6.19m |
| Earnings (TTM) | -€1.54b |
| Revenue (TTM) | €22.04b |
0.0x
P/S Ratio0.0x
P/E RatioIs RTA1 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RTA1 income statement (TTM) | |
|---|---|
| Revenue | US$23.48b |
| Cost of Revenue | US$18.75b |
| Gross Profit | US$4.73b |
| Other Expenses | US$6.36b |
| Earnings | -US$1.64b |
Last Reported Earnings
Sep 02, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -29.75 |
| Gross Margin | 20.14% |
| Net Profit Margin | -6.97% |
| Debt/Equity Ratio | -191.6% |
How did RTA1 perform over the long term?
See historical performance and comparison